Arthur Vandenbark

Professor

Professor, Neurology

Emailvandenba@ohsu.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Arthur Vandenbark is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Not started
6 Finished

BLR&D Research Career Scientist Award Application
Vandenbark, A.
Project: Research project
Development of DR?1-MOG-35-55 for treatment of DR2 negative MS subjects
Vandenbark, A.
National Institutes of Health
2/1/16 → 1/31/17
Project: Research project
Immunoregulation of Myelin Specific T Lymphocytes
Vandenbark, A.
National Institutes of Health
4/1/09 → 12/31/16
Project: Research project
REGULATION OF EAE WITH RECOMBINANT TCR LIGANDS
Vandenbark, A.
National Institutes of Health
12/1/03 → 3/31/16
Project: Research project
Development of a T cell specific multiple sclerosis drug
Vandenbark, A.
National Institutes of Health
9/30/03 → 8/31/07
Project: Research project

13694 Citations
60 h-Index
300 Article
18 Review article
5 Comment/debate
2 Letter
More
- 1 Chapter
- 1 Short survey

Sex differences in EAE reveal common and distinct cellular and molecular components
Wiedrick, J., Meza-Romero, R., Gerstner, G., Seifert, H., Chaudhary, P., Headrick, A., Kent, G., Maestas, A., Offner, H. & Vandenbark, A. A., Jan 2021, In: Cellular Immunology. 359, 104242.
Research output: Contribution to journal › Article › peer-review
A Novel Partial MHC Class II Construct, DRmQ, Inhibits Central and Peripheral Inflammatory Responses to Promote Neuroprotection in Experimental Stroke
Lee, J. Y., Castelli, V., Bonsack, B., Coats, A. B., Navarro-Torres, L., Garcia-Sanchez, J., Kingsbury, C., Nguyen, H., Vandenbark, A. A., Meza-Romero, R., Offner, H. & Borlongan, C. V., Aug 1 2020, In: Translational Stroke Research. 11, 4, p. 831-836 6 p.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations
Partial MHC/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C–C motif) ligand 2 levels in rats
Loftis, J. M., Navis, T., Taylor, J., Hudson, R., Person, U., Lattal, K. M., Vandenbark, A. A., Shirley, R. & Huckans, M., Aug 5 2020, In: European Journal of Pharmacology. 880, 173175.
Research output: Contribution to journal › Article › peer-review
Spleen participation in partial MHC class II construct neuroprotection in stroke
Brown, J., Kingsbury, C., Lee, J. Y., Vandenbark, A. A., Meza-Romero, R., Offner, H. & Borlongan, C. V., Jul 1 2020, In: CNS Neuroscience and Therapeutics. 26, 7, p. 663-669 7 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
1 Scopus citations
Surviving the storm: Dealing with COVID-19
Vandenbark, A. A., Meza-Romero, R. & Offner, H., Aug 2020, In: Cellular Immunology. 354, 104153.
Research output: Contribution to journal › Letter › peer-review

2 Scopus citations